Flu vaccine market set to expand by 2021

According to research recently published by Research Nester, the global influenza vaccine market is expected to reach $45.25 billion by 2021.

This increase represents a CAGR of 7.9% and is anticipated as a result of the equal chance of influenza occurring in both developed and developing nations. In 2010, the US was the largest influenza vaccine market, followed by China.

Rapidly growing population levels and an increase in land acquisition for the required infrastructural facilities would lead to a higher rate of influenza casualties, report Research Nester. This increase in influenza casualties would therefore relate to an increase in the influenza vaccine market.

Moreover, the rising medical healthcare services and governmental initiatives, such as vaccination programmes, are projected to boost the demand of influenza vaccines.

Research Nester is a service provider for strategic marker research and consulting.